Morphologic interpretation is the standard in diagnosing myelodysplastic syndrome (MDS),
but it has limitations, such as varying reliability in pathologic evaluation and lack of …

Cytoplasmic vacuoles in precursors can be seen in a number of clinical settings, including
copper deficiency, zinc toxicity, alcohol abuse, antibiotic treatment, myelodysplasia, and …

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of peripheral T-cell
lymphoma affecting younger patients and associated with hemophagocytic …

Idiopathic aplastic anemia (IAA) is a rare autoimmune bone marrow failure (BMF) disorder
initiated by a human leukocyte antigen (HLA)-restricted T-cell response to unknown antigens. …

Eltrombopag, an FDA-approved non-peptidyl thrombopoietin receptor agonist, is clinically
used for the treatment of aplastic anemia, a disease characterized by hematopoietic stem cell …

Germline HAVCR2 mutations are frequently detected in subcutaneous panniculitis-like T-cell
lymphoma (SPTCL) patients with/without hemophagocytic lymphohistiocytosis (HLH) but …

Germline DDX41 mutations were recently reported to cause MDS/AML and donor-derived
leukemia after transplantation. While previously described in Western countries, DDX41 …

Decrease in DNA dioxygenase activity generated by TET2 gene family is crucial in myelodysplastic
syndromes (MDS). The general downregulation of 5-hydroxymethylcytosine (5-hmC) …

TCR repertoire diversification constitutes a foundation for successful immune reconstitution
after allogeneic hematopoietic cell transplantation (allo-HCT). Deep TCR Vβ sequencing of …

Good syndrome (GS), originally described in 1954 by Dr Robert Good in a series of three
patients, classically comprises hypogammaglobulinemia (HG) and thymoma [1]. We …